Sort
64,565 grants matching “drug discovery”
Novel Therapies for Alcoholic Hepatitis
$526,938Arthur J McCullough · Cleveland Clinic Lerner Com-Cwru · U01 · FY2017 · AA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$526,891Albert Folch · University Of Washington · R01 · FY2022 · CA
mitoNEET as a therapeutic target for mitigating ischemic brain injury following MCAO
$526,872Jason D Huber · West Virginia University · R01 · FY2024 · NS
Exploring Novel Epilepsy Pathways
$526,864Alexander G Bassuk · University Of Iowa · R01 · FY2016 · NS
Aim 4: Target discovery for common disease mechanisms
$526,812Peter Karl Sorger · Harvard Medical School · P50 · FY2015 · GM
PrEP uptake/adherence to reduce periconception HIV risk for South African women
$526,767Lynn T Matthews · University Of Alabama At Birmingham · R01 · FY2020 · MH
Regulation of Gene Expression During Stress
$526,731Maria Hatzoglou · Case Western Reserve University · R01 · FY2021 · DK
Mechanisms of Synaptic Dopamine Signaling in the Control of Behavior
$526,666Niels Ringstad · New York University School Of Medicine · R01 · FY2023 · NS
Mechanisms of synaptic dopamine signaling in the control of behavior
$526,666Niels Ringstad · New York University School Of Medicine · R01 · FY2021 · NS
Mechanisms of synaptic dopamine signaling in the control of behavior
$526,666Niels Ringstad · New York University School Of Medicine · R01 · FY2022 · NS
Genetic and social determinants of pharmacological health outcomes in ancestrally diverse populations
$526,647Akinyemi Oni-Orisan · University Of California, San Francisco · R01 · FY2024 · HG
Genetic and social determinants of pharmacological health outcomes in ancestrally diverse populations
$526,615Akinyemi Oni-Orisan · University Of California, San Francisco · R01 · FY2025 · HG
Phase I Studies of Targeted Anti-Cancer Therapies
$526,608University Of Texas Md Anderson Can Ctr · U01 · FY2005 · CA
Assay development and screening for inhibitors targeting Shiga toxin 2
$526,594Xiao-Ping Li · Rutgers, The State Univ Of N.J. · R01 · FY2019 · AI
HTS for Synergistic Activators of Latent HIV-1 Infection
$526,579Olaf Kutsch · University Of Alabama At Birmingham · R01 · FY2015 · AI
HTS for Synergistic Activators of Latent HIV-1 Infection
$526,579Olaf Kutsch · University Of Alabama At Birmingham · R01 · FY2014 · AI
Identifying and Targeting Mechanisms for Membrane Signaling in Human Cancer
$526,562Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2024 · CA
Molecular Basis for Transmembrane Conduction & Signaling
$526,524Robert M Stroud · University Of California, San Francisco · R37 · FY2016 · GM
Engineering the Vocal Fold Extracellular Matrix
$526,517Susan L Thibeault · University Of Wisconsin-Madison · R01 · FY2012 · DC
Motor neuron selector genes and mechanism of their action
$526,427Hynek Wichterle · Columbia University Health Sciences · R01 · FY2016 · NS
SITE-DIRECTED DRUG DISCOVERY
$526,420Sunesis Pharmaceuticals, Inc. · R44 · FY2002 · CA
Systemic RNA Delivery to Tumors
$526,391Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2019 · CA
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection
$526,238Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection
$526,238Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
Microglia-targeted glutaminase inhibition forthe treatment of chronic stress-associated depression
$526,191Xiaolei Zhu · Johns Hopkins University · R56 · FY2024 · MH